Cargando…

HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses

BACKGROUND: Heterosexual transmission remains the main route of HIV-1 transmission and female genital tract (FGT) inflammation increases the risk of infection. However, the mechanism(s) by which inflammation facilitates infection is not fully understood. In rhesus macaques challenged with simian imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lumngwena, Evelyn Ngwa, Metenou, Simon, Masson, Lindi, Cicala, Claudia, Arthos, James, Woodman, Zenda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331269/ https://www.ncbi.nlm.nih.gov/pubmed/32615983 http://dx.doi.org/10.1186/s12977-020-00526-0

Ejemplares similares

Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10
por: Lumngwena, Evelyn Ngwa, et al.
Publicado: (2020)

HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression
por: Lumngwena, Evelyn Ngwa, et al.
Publicado: (2019)

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses
por: Luthuli, Bonisile, et al.
Publicado: (2023)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
por: O’Brien, Sean P., et al.
Publicado: (2019)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV
por: Cicala, Claudia, et al.
Publicado: (2011)

Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences
por: Song, Hongshuo, et al.
Publicado: (2016)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency
por: Sutherland, Katherine A., et al.
Publicado: (2016)

Uterine Epithelial Cell Regulation of DC-SIGN Expression Inhibits Transmitted/Founder HIV-1 Trans Infection by Immature Dendritic Cells
por: Ochiel, Daniel O., et al.
Publicado: (2010)

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection
por: Kijak, Gustavo H., et al.
Publicado: (2017)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
por: Ananthaswamy, Neeti, et al.
Publicado: (2019)

Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1
por: Nijmeijer, Bernadien M., et al.
Publicado: (2019)

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains
por: Lucas, Julie, et al.
Publicado: (2023)

Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection
por: Kijak, Gustavo H., et al.
Publicado: (2017)

Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner
por: Frange, Pierre, et al.
Publicado: (2013)

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome
por: Song, Hongshuo, et al.
Publicado: (2012)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
por: Salazar-Gonzalez, Jesus F., et al.
Publicado: (2016)

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashok kumar, Manickam, et al.
Publicado: (2020)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
por: Hertoghs, Nina, et al.
Publicado: (2019)

Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006–2011)
por: Balinda, Sheila N., et al.
Publicado: (2022)

Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes
por: Madlala, Paradise, et al.
Publicado: (2023)

The HIV-1 envelope protein gp120 is captured and displayed for B cell recognition by SIGN-R1(+) lymph node macrophages
por: Park, Chung, et al.
Publicado: (2015)

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
por: Goonetilleke, Nilu, et al.
Publicado: (2009)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

HIV-1 Subtype and Reverse Transcriptase Genotype: Role for Geographical Location and Founder Effects
por: Ojesina, Akinyemi I, et al.
Publicado: (2006)

Rapid Point-of-Care Testing for Genital Tract Inflammatory Cytokine Biomarkers to Diagnose Asymptomatic Sexually Transmitted Infections and Bacterial Vaginosis in Women: Cost Estimation and Budget Impact Analysis
por: Kairu, Angela, et al.
Publicado: (2022)

Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
por: Parrish, Nicholas F., et al.
Publicado: (2012)

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
por: Salazar-Gonzalez, Jesus F., et al.
Publicado: (2009)

Rectal Transmission of Transmitted/Founder HIV-1 Is Efficiently Prevented by Topical 1% Tenofovir in BLT Humanized Mice
por: Chateau, Morgan L., et al.
Publicado: (2013)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
por: Kumar, Amit, et al.
Publicado: (2018)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019)

Polygenic risk scores of several subtypes of epilepsies in a founder population
por: Moreau, Claudia, et al.
Publicado: (2020)

Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa
por: Woodman, Zenda
Publicado: (2016)

Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection
por: Tovanabutra, Sodsai, et al.
Publicado: (2019)

South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication
por: Richardson, Simone I, et al.
Publicado: (2015)

The Genotype of Early-Transmitting HIV gp120s Promotes α(4)β(7) –Reactivity, Revealing α(4)β(7) (+)/CD4(+) T cells As Key Targets in Mucosal Transmission
por: Nawaz, Fatima, et al.
Publicado: (2011)

Beneficial HLA-mediated viral polymorphisms on the transmitted virus additively influence disease progression in HIV-1, subtype C infection
por: Ntale, RS, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cm7frk9l5qt99k7gtpcdsk1cga